Meteora Capital’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Meteora Capital’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-80,646	Closed	-$24.2K	–	366
2023 Q4	$24.2K	Hold	80,646	–	–	﹤0.01%	214
2023 Q3	$28.1K	Hold	80,646	–	–	﹤0.01%	232
2023 Q2	$12.9K	Hold	80,646	–	–	﹤0.01%	246
2023 Q1	$11.7K	Hold	80,646	–	–	﹤0.01%	288
2022 Q4	$4.84K	Buy	80,646 +55,461	+220%	+$3.17K	﹤0.01%	265
2022 Q3	$1K	Sell	25,185 -3,361	-12%	-$371	﹤0.01%	377
2022 Q2	$3K	Buy	+28,546	New	+$4.65K	﹤0.01%	444

Meteora Capital's DMAQR Position: Q1 2024 in Review

Meteora Capital sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 80,646 shares — an estimated $24.2K sold.

Meteora Capital first reported a position in DMAQR in Q2 2022 and held it in 7 quarters. The position peaked at $28.1K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Meteora Capital reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Meteora Capital sold 80,646 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $24.2K.
Meteora Capital first reported a position in Deep Medicine Acquisition Corp. Rights in Q2 2022 and held it in 7 quarters.
Meteora Capital's Deep Medicine Acquisition Corp. Rights position peaked at $28.1K in Q3 2023.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Meteora Capital's 13F filing for Q1 2024, filed 14 May 2024.